PD09-06 PROSTATE CANCER IS LESS FREQUENT AND SEVERE IN HYPOGONADAL MEN TREATED ADEQUATELY WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) FOR UP TO 8 YEARS COMPARED TO UNTREATED HYPOGONADAL CONTROLS

Abstract

shared decision making (SDM) has become increasingly important. The objectives of this study were to determine who made the final decision to obtain prostate-specific antigen (PSA)-based screening and identify factors associated with the screening decision made by both patients and their health care providers. METHODS: Using the 2013 Behavioral Risk Factor Surveillance System data from Delaware, Hawaii, and Massachusetts, we calculated weighted percentages of SDM. Associations between the SDM and sociodemographic, lifestyle, access to care, and PSA testing-related factors were assessed by using multivariate logistic regression. RESULTS: There were 2,248 men aged 40 years or older who had ever had a PSA test for cancer screening in the 3 states in 2013. Only 36% of men made their prostate cancer screening decision jointly with their health care provider. Multivariate logistic regression analysis showed that shared decision making was reported more frequently by men who had ever participated in a discussion about prostate cancer screening (P 1⁄4 0.0001), or men whose most recent PSA test occurred within the past year (P 1⁄4 0.04). CONCLUSIONS: The majority of screening decisions were made by the patient or health care provider alone in these three states, not jointly, as recommended. Our study points to the needs for increased use of higher quality, patient-engaged, and preference-elicited shared decision making.